Pathfinder Cell Therapy Inc (PFND)

Pathfinder Cell Therapy Financial Statements


Pathfinder Cell Therapy Financial Overview

Pathfinder Cell Therapy's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Pathfinder Cell Therapy is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 15Jun 15Mar 15Dec 14Sep 14
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
EBIT$ -209.00K$ -144.00K$ -204.00K$ -218.00K$ -213.00K
EBITDA$ -208.00K$ -143.00K$ -203.00K$ -218.00K$ -212.00K
Net Income Common Stockholders$ -289.00K$ -222.00K$ -276.00K$ -293.00K$ -284.00K
Balance Sheet
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 4.00K$ 21.00K$ 23.00K$ 26.00K
Total Assets$ 39.00K$ 49.00K$ 86.00K$ 106.00K$ 70.00K
Total Debt$ 4.80M$ 4.98M$ 5.15M$ 5.23M$ 5.41M
Net Debt$ 4.80M$ 4.98M$ 5.13M$ 5.21M$ 5.39M
Total Liabilities$ 6.77M$ 6.49M$ 6.30M$ 6.05M$ 5.72M
Stockholders Equity$ -6.73M$ -6.44M$ -6.22M$ -5.94M$ -5.65M
Cash Flow
Free Cash Flow$ -178.00K$ -98.00K$ -176.00K$ -127.00K$ -228.00K
Operating Cash Flow$ -178.00K$ -98.00K$ -176.00K$ -127.00K$ -228.00K
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ ―$ 0.00
Financing Cash Flow$ 182.00K$ 77.00K$ 171.00K$ 130.00K$ 230.00K
Currency in USD

Pathfinder Cell Therapy Earnings and Revenue History

Pathfinder Cell Therapy Debt to Assets

Pathfinder Cell Therapy Cash Flow

Pathfinder Cell Therapy Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis